HPV Vaccination Resources

Mar. 2025Important Notices

To help protect against cancers later in life, it is important to increase HPV vaccination rates in adolescents starting at age 9. According to the Centers for Disease Control and Prevention, HPV vaccination is routinely recommended at age 11 or 12, but the vaccine can be given starting at age 9.1 The Pennsylvania Cancer Coalition cites the following potential benefits of initiating the HPV vaccine series at age 9.2

  • More time to complete the series by age 13
  • Strong immune response to the HPV vaccine
  • Increased likelihood of vaccinating before the first HPV exposure
  • Fewer questions about sexual activity by parents and guardians
  • Fewer requests for only vaccines that are “required” for school
  • Fewer shots per visit
  • Highly acceptable to systems, providers, and parents

You can use these resources from the American Cancer Society National HPV Vaccination Roundtable and Pennsylvania Cancer Coalition to support your efforts to begin recommending HPV vaccination at age 9:

As your partner in care, UPMC Health Plan is also here as a resource for you. If you have questions about this effort or ways your practice can help achieve goals around it, please contact your physician account executive or call Provider Services at 1-866-918-1595.

UPMC Health Plan does not practice medicine or exercise control over the methods or professional judgments by which providers render medical services to members. Nothing in these materials should be construed to supersede or replace the clinical judgment of a provider. 


1Centers for Disease Control and Prevention. Human papillomavirus vaccination for adults: Updated recommendations of the Advisory Committee on Immunization Practices. Aug. 16, 2019. Accessed March 24, 2025. cdc.gov/mmwr/volumes/68/wr/mm6832a3.htm

2Pennsylvania Cancer Coalition. Start recommending HPV vaccination at age 9. March 2025.


Recent Announcements

February 2026 UPMC for You and UPMC Community HealthChoices formulary update

Pulmicort Flexhaler has a new distributor, Rubicon Holding. National Drug Codes (NDCs) for Pulmicort Flexhaler from Rubicon Holding are not included in the Medicaid Drug Rebate program and are not covered under the Medicaid Prescription Drug Program. Pulmicort Flexhaler NDCs from the previous manufacturer, H2 Pharma, have been discontinued but may be billed/dispensed until supplies are exhausted.
Feb. 2026Pharmacy Updates

CME Webinar: American Foundation for Suicide Prevention’s ‘Talk Saves Lives’ Program

Please join us on Tuesday, April 28, from noon to 1 p.m. for “Talk Saves Lives: An Introduction to Suicide Prevention.” This live, CME-accredited webinar is the American Foundation for Suicide Prevention’s flagship suicide prevention education program. It covers the scope of this leading cause of death, warning signs and risk factors for suicide, and strategies to prevent it.
Feb. 2026Education/Webinars

Training Webinar: Conversio Health COPD Management Program

Please join us for a live training webinar by UPMC Health Plan that will provide an overview of a comprehensive COPD management program from Conversio Health.
Jan. 2026Education/Webinars